Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. 4 de
Alasaadi DN et al. (2024)
|
Xla Wt + wnt8a
NF16-17 (in situ hybridization)
|
|
|
|
Fig. 4 de
Alasaadi DN et al. (2024)
|
Xla Wt + wnt8a + yap1 MO
NF16-17 (in situ hybridization)
|
|
|
|
Fig.4.H
Gur M et al. (2022)
|
Xla Wt + wnt8a
NF10.25 (RT-PCR)
|
|
|
|
Fig.4.H
Gur M et al. (2022)
|
Xla Wt + wnt8a
NF11 (RT-PCR)
|
|
|
|
Fig.4.H
Gur M et al. (2022)
|
Xla Wt + wnt8a
NF13 (RT-PCR)
|
|
|
|
Fig. 7 BD
Kreis J et al. (2021)
|
Xla Wt + wnt8a
NF10-11.5 (in situ hybridization)
|
|
|
|
Fig.2.C
Chen M et al. (2020)
|
Xla Wt + wnt8a + animal cap explant
NF10 (RT-PCR)
|
|
|
|
Fig.6.C
Ossipova O et al. (2020)
|
Xla Wt + wnt8a + animal cap explant
NF10.5-11 (RT-PCR)
|
|
|
|
Fig. 3B, row1, col4
Chang LS et al. (2020)
|
Xtr WT + wnt8a
NF 18 (in situ hybridization)
|
|
|
|
Fig. 3B, row2, col4
Chang LS et al. (2020)
|
Xtr WT + wnt8a
NF 18 (in situ hybridization)
|
|
|